Characterizing subsequent primary melanomas (SPM) in adolescents and young adults: A population-based study from 1973 to 2011 - 18/12/15
Doi : 10.1016/j.jaad.2015.09.003
Teresa Fu, MD a, Susan M. Swetter, MD a, b, Li Tao, PhD, MD, MS c, Alan C. Geller, MPH, RN d, Christina A. Clarke, PhD, MPH c, e, Theresa H.M. Keegan, PhD, MS c, f, ⁎ 
a Department of Dermatology, Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, California
b Dermatology Service, Department of Veterans Affairs Palo Alto Health Care System, California
c Cancer Prevention Institute of California, Fremont, California
d Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, Massachusetts
e Division of Epidemiology, Department of Health Research and Policy, Stanford University School of Medicine, California
f Division of Hematology and Oncology, Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, California
∗Correspondence to: Theresa H. M. Keegan, PhD, MS, Division of Hematology and Oncology, Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, 4501 X St, Suite 3016, Sacramento, CA 95817
| The Cancer Prevention Institute of California received research funding from Genentech. This work was supported by the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute (NCI) at the National Institutes of Health under contract HHSN2612010000140C awarded to the Cancer Prevention Institute of California (Drs Tao, Clarke, and Keegan) and the Stanford Cancer Institute (Drs Clarke and Keegan). The collection of cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the NCI SEER Program under contract HHSN2612010000140C awarded to the Cancer Prevention Institute of California, contract HHSN261201000035C awarded to the University of Southern California, and contract HHSN261201000034C awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement #1U58 DP000807-01 awarded to the Public Health Institute. The ideas and opinions expressed herein are those of the authors and endorsement by the State of California, Department of Health Services, the NCI, and the Centers for Disease Control and Prevention or their contractors and subcontractors is not intended nor should be inferred. The funder did not have any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. |
|
| Conflicts of interest: None declared. |
© 2015
American Academy of Dermatology, Inc. Tous droits réservés.
Vol 74 - N° 1
P. 181 - janvier 2016 Retour au numéro
Article précédent
- Compliance with the College of American Pathologists Protocol for Melanoma in Synoptic and Non-Synoptic reports: A cross-sectional study
- Alexander Maley, Samit Patrawala, Benjamin Stoff
- “I didn't sign on to die”: The dermatologist's ethical obligations during a deadly epidemic
- Daniel J. Shaw, Michelle Maciag, Lionel Bercovitch
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?